about
Mechanism and significance of cell type-dependent neutralization of flavivirusesShake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostA CRISPR screen defines a signal peptide processing pathway required by flavivirusesBroadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeZika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other FlavivirusesDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusHigh-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infectionMaternal Neutralizing Antibody and Transmission of Hepatitis C Virus to InfantsStructural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic EpitopeNetrin binds discrete subdomains of DCC and UNC5 and mediates interactions between DCC and heparinZika virus protection by a single low-dose nucleoside-modified mRNA vaccinationA single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisSpontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virusSelection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virusCombined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.Rapid development of a DNA vaccine for Zika virusAntibody-mediated neutralization of flaviviruses: a reductionist view.The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases.Hepatitis C virus infection of neuroepithelioma cell lines.Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibodyContext-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus AssemblyCD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency VirusGenotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing.Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.B cell response and mechanisms of antibody protection to West Nile virus.Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.Enhancing dengue virus maturation using a stable furin over-expressing cell linePseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection.Modified mRNA Vaccines Protect against Zika Virus Infection.Structural Basis of Zika Virus-Specific Antibody Protection.A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.Modified mRNA Vaccines Protect against Zika Virus Infection.
P50
Q23032973-BA6AF10F-3796-44C5-829B-F38774A35994Q23925011-CB3514BE-C6D6-4B53-A43F-4F22B3E27821Q24705237-94FF4EBA-89B6-4BFC-BBEE-66F81D0D7671Q26252060-093FB0B7-D4E2-4BF7-9A0B-BB20F657EFD2Q26970782-EFEC043E-D91A-4A11-AFFA-B7CA3566C858Q27335008-0DCA9C0F-6D69-4AAF-8241-464A2297788BQ27490345-B51037A9-A882-456E-B627-C4E0B0DB11CFQ27490404-832D45B6-6BB3-4E67-947E-88E84D15E21EQ27674417-C444B6AD-0013-4100-892A-FEC4E6D3F365Q28179787-0AFD586C-7ABC-40D5-8F1F-678F5246BD04Q28656365-090B55C8-1157-49A2-A0DC-B6E60E19BD31Q28804076-4850D141-85A5-4846-AFF5-64E01F7918C3Q33929089-1379CEA1-6229-4396-AEE1-B5601DC37AC3Q33954392-D8E696E8-2EA2-4041-ABFA-ED0EC0B8C0E7Q33955998-BECDB80E-AA74-4FB5-9719-05F6B837A450Q34120070-2422C4B4-20E7-4773-A6B8-3E5EA35C061FQ34132718-E3B2A4EC-BA38-4CF3-8394-37D29FCA6FBCQ34261496-1AE538C1-2DEE-44AA-8BA8-CA6FE6CC5140Q34542032-6C61D925-4A2D-464B-8C1F-97FAD60C7735Q34999617-B24BB904-4705-418F-AD2E-982404FA412AQ35069160-CB7A48B0-6BAE-4C1E-BEAD-1BF68F873CD0Q35152094-3F1872FC-F7BB-4141-8783-FA57E41431DAQ35531167-1570331E-E1FD-41B5-8863-4E781CF91036Q35531189-836D602F-5726-4D2D-B16E-1ED88F59703BQ35818245-D632C0B3-C4F8-425D-9E06-69F44C7F72E8Q35854520-5D619476-F5FD-4987-8846-ED5C6F13FD78Q35914284-58C889D9-233C-490F-8DBE-4193F93B66B8Q35993488-5AF5DB35-0779-4C7B-BA01-22ED67A3F2EAQ36245225-8CEED251-B101-4AFB-A823-01E8072B465BQ36697323-413062FE-DAD7-40C3-A6F6-EFAE9209C1C2Q37336735-39675BC3-5CFD-4F87-92DE-9A8285E211C9Q37673123-B1439FD0-277B-4EC2-A42D-7D7C3E14C2DBQ38157833-970C9606-51F4-4708-8F3E-D1B885FCAB08Q38758003-D50CD53A-C103-4D34-9588-A4158679C9D5Q39008700-99CA6304-E6F1-492A-8038-1BB1902A376FQ40049416-1AD9CA79-2EF4-4912-8D53-6C8CBAF02898Q40056291-93A8D97E-85E1-4D98-B9E3-AB97EF65D790Q40082746-10E55184-A90E-4F33-8C77-D8C7B777A44BQ40341996-404C67E8-A707-4CD2-A787-97DB1D748170Q41981700-1C460F52-0BF3-4BD9-93E0-7D676CA73707
P50
name
Kimberly A Dowd
@ast
Kimberly A Dowd
@en
Kimberly A Dowd
@nl
type
label
Kimberly A Dowd
@ast
Kimberly A Dowd
@en
Kimberly A Dowd
@nl
prefLabel
Kimberly A Dowd
@ast
Kimberly A Dowd
@en
Kimberly A Dowd
@nl